WHO scientist: Trial suspension a 'wake-up call'
- Country:
- United Kingdom
The World Health Organization's chief scientist says the agency isn't overly worried about the pause in the clinical trials for a coronavirus vaccine developed by Oxford University and AstraZeneca. Dr. Soumya Swaminathan called the pause in Oxford's clinical trial "a wake-up call" to the global community to realize "there are ups and downs in research." Swaminathan says early data in human vaccine candidates so far has been "quite promising," showing the shots trigger an immune response.
But she says trials must be conducted in tens of thousands of people to determine whether a vaccine can safely protect people from infection. "It could be that we see some results end of the year, it could be next year," she said.
"We have to be a little bit patient and wait for the results.".
ALSO READ
-
Revolutionizing Cancer Care: AstraZeneca and Roche's Pioneering AI Partnership
-
Hantavirus requires prolonged close contact for transmission unlike Covid: Soumya Swaminathan
-
Attacks on hospitals and medics rising, driven by Middle East conflict, says World Health Organization
-
UPDATE 2-AstraZeneca to invest $405 million in Britain after US-UK pharma deal
-
UPDATE 1-AstraZeneca plans to invest $405 million in Britain, PM Starmer says
Google News